IGM Biosciences (IGMS) News Today $1.31 +0.04 (+3.15%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.28 -0.03 (-2.29%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IGMS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period IGM Biosciences (NASDAQ:IGMS) Announces Earnings ResultsAugust 2 at 8:45 PM | marketbeat.comIGM Biosciences, Inc. (NASDAQ:IGMS) CFO Misbah Tahir Sells 8,741 SharesJuly 26, 2025 | marketbeat.comMary Beth Harler Sells 14,501 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) StockJuly 26, 2025 | marketbeat.comIGM Biosciences, Inc. (NASDAQ:IGMS) CFO Sells $11,101.07 in StockJuly 26, 2025 | insidertrades.comIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Reduce" from BrokeragesJuly 20, 2025 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Trading Down 5.9% - Here's WhyJuly 17, 2025 | marketbeat.comIGM Biosciences Enters Definitive Merger Agreement with Concentra Biosciences for Acquisition - NasdaqJuly 3, 2025 | nasdaq.comIGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right - Seeking AlphaJuly 3, 2025 | seekingalpha.comIGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to Shareholders - MorningstarJuly 3, 2025 | morningstar.comMIGM Biosciences Shares Surge on Takeover Agreement with ConcentraJuly 2, 2025 | msn.comIGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to ShareholdersJuly 1, 2025 | businesswire.comIGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value RightJuly 1, 2025 | globenewswire.comTruist Financial Lowers IGM Biosciences (NASDAQ:IGMS) Price Target to $1.00June 11, 2025 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Rating Lowered to "Sell" at Wall Street ZenJune 7, 2025 | marketbeat.comIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Reduce" from AnalystsJune 1, 2025 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Upgraded to "Hold" at Wall Street ZenMay 31, 2025 | marketbeat.comIGM Biosciences Terminates Headquarters Lease AgreementMay 29, 2025 | tipranks.comIGM Biosciences earnings missed by $0.51, revenue fell short of estimatesMay 24, 2025 | investing.comSanofi Purchases New Shares in IGM Biosciences, Inc. (NASDAQ:IGMS)May 19, 2025 | marketbeat.comIGM Biosciences ends agreement with SanofiMay 10, 2025 | investing.comIGM Biosciences (IGMS) to Release Earnings on WednesdayMay 9, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 445,260 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS)May 4, 2025 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Stock Price Down 1.5% - Should You Sell?April 30, 2025 | marketbeat.comBank of America Securities downgrades IGM Biosciences (IGMS) to a SellApril 9, 2025 | markets.businessinsider.comIGM Biosciences, Inc. (NASDAQ:IGMS) Sees Large Decline in Short InterestApril 1, 2025 | marketbeat.comIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of "Reduce" from AnalystsMarch 25, 2025 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Shares Up 5.9% - Here's WhyMarch 25, 2025 | marketbeat.comIGM Biosciences (IGMS) Gets a Hold from RBC CapitalMarch 7, 2025 | markets.businessinsider.comMorgan Stanley Sticks to Their Sell Rating for IGM Biosciences (IGMS)March 7, 2025 | markets.businessinsider.comIGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of "Reduce" from BrokeragesFebruary 28, 2025 | marketbeat.comIGM Biosciences (IGMS) Projected to Post Quarterly Earnings on ThursdayFebruary 27, 2025 | marketbeat.comIgm BiosciencesFebruary 16, 2025 | forbes.comIGM Biosciences (IGMS) Receives a Hold from Bank of America SecuritiesFebruary 13, 2025 | markets.businessinsider.comIGM Biosciences stock plunges to 52-week low of $1.59January 28, 2025 | msn.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMSJanuary 28, 2025 | prnewswire.comIgm biosciences principal accounting officer sells $1,907 in stockJanuary 17, 2025 | msn.comBank of America Securities Sticks to Their Hold Rating for IGM Biosciences (IGMS)January 13, 2025 | markets.businessinsider.comJPMorgan Chase & Co. Upgrades IGM Biosciences (NASDAQ:IGMS) to NeutralJanuary 13, 2025 | marketbeat.comIGM Biosciences downgraded to Hold from Buy at JefferiesJanuary 11, 2025 | finance.yahoo.comIGM Biosciences upgraded to Neutral from Underweight at JPMorganJanuary 11, 2025 | markets.businessinsider.comStifel Downgrades IGM Biosciences (IGMS)January 11, 2025 | msn.comJefferies downgrades IGM Biosciences (IGMS) to a HoldJanuary 10, 2025 | markets.businessinsider.comIGM Biosciences Stock: Bad News With No Turnaround In SightJanuary 10, 2025 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: IGM Biosciences (IGMS) and Abivax SA Sponsored ADR (ABVX)January 10, 2025 | markets.businessinsider.comIGM Biosciences to cut 73% of workforce as latest pivot fails to pan out, sending stock down 69%January 10, 2025 | msn.comIGM Bio plunges as Wall Street downgrades on portfolio shakeupJanuary 10, 2025 | msn.comJefferies Financial Group Reiterates "Hold" Rating for IGM Biosciences (NASDAQ:IGMS)January 10, 2025 | marketbeat.comIGM Biosciences (NASDAQ:IGMS) Price Target Cut to $2.00 by Analysts at Truist FinancialJanuary 10, 2025 | marketbeat.comIGM Biosciences' (IGMS) Neutral Rating Reaffirmed at WedbushJanuary 10, 2025 | marketbeat.comIGM Biosciences halts development of auto-immune treatments, shares plummetJanuary 10, 2025 | au.investing.com Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address IGMS Media Mentions By Week IGMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGMS News Sentiment▼1.380.45▲Average Medical News Sentiment IGMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGMS Articles This Week▼22▲IGMS Articles Average Week Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IVA News VOR News ESPR News SCPH News BNTC News HRTX News MREO News TKNO News ANNX News LFCR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IGMS) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
